UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Fluoride Administered and Retained After Topical Fluoride Varnish

Early Phase 1

Completed

Conditions: Healthy

Interventions: Device: Fluoride varnish

First Posted Date: 2012-12-21

Last Posted Date: 2018-05-07

Lead Sponsor: University of Washington

Target Recruit Count: 6

Registration Number: NCT01754831

Locations: 🇺🇸
UW Center for Pediatric Dentistry, Seattle, Washington, United States

A Client-Based Outcome System for Individuals With Lower Limb Amputation

Completed

Conditions: Amputation

First Posted Date: 2012-12-17

Last Posted Date: 2016-05-18

Lead Sponsor: University of Washington

Target Recruit Count: 1572

Registration Number: NCT01750372

Locations: 🇺🇸
South Florida Veterans Affairs Foundation for Research and Education, Miami, Florida, United States
🇺🇸
University of Washington, UWCORR, Seattle, Washington, United States

Endotracheal Tubes for Prevention of Ventilator-associated Pneumonia

Not Applicable

Completed

Conditions: Ventilator-acquired Pneumonia

Interventions: Device: PVC ETT
Device: PUC ETT
Device: PUC-CASS ETT

First Posted Date: 2012-12-06

Last Posted Date: 2017-10-26

Lead Sponsor: University of Washington

Target Recruit Count: 117

Registration Number: NCT01744483

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States

Fecal Microbiota Transplantation for Ulcerative Colitis

Not Applicable

Terminated

Conditions: Ulcerative Colitis

Interventions: Other: Fecal Microbiota Transplantation

First Posted Date: 2012-12-05

Last Posted Date: 2013-11-13

Lead Sponsor: University of Washington

Target Recruit Count: 7

Registration Number: NCT01742754

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer

Not Applicable

Completed

Conditions: Stage IV Prostate Cancer
Prostate Adenocarcinoma
Stage IIB Prostate Cancer
Stage IIA Prostate Cancer
Stage III Prostate Cancer

Interventions: Drug: Degarelix
Radiation: External Beam Radiation Therapy
Other: Laboratory Biomarker Analysis

First Posted Date: 2012-11-22

Last Posted Date: 2019-01-18

Lead Sponsor: University of Washington

Target Recruit Count: 16

Registration Number: NCT01731912

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer

Phase 2

Terminated

Conditions: Stage IVA Colon Cancer
Stage IVA Rectal Cancer
Stage IVB Colon Cancer
Stage IVB Rectal Cancer
Recurrent Colon Carcinoma
Recurrent Rectal Carcinoma

Interventions: Drug: Capecitabine
Drug: Celecoxib
Radiation: Intensity-Modulated Radiation Therapy
Other: Laboratory Biomarker Analysis
Other: Quality-of-Life Assessment
Radiation: Radiation Therapy
Radiation: Stereotactic Radiosurgery
Procedure: Therapeutic Conventional Surgery

First Posted Date: 2012-11-20

Last Posted Date: 2018-01-16

Lead Sponsor: University of Washington

Target Recruit Count: 27

Registration Number: NCT01729923

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer

Phase 2

Terminated

Conditions: HER2-positive Breast Cancer
Stage IV Breast Cancer
Male Breast Cancer
Recurrent Breast Cancer

Interventions: Biological: HER-2/neu peptide vaccine

First Posted Date: 2012-11-20

Last Posted Date: 2017-04-11

Lead Sponsor: University of Washington

Target Recruit Count: 3

Registration Number: NCT01729884

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients

Not Applicable

Completed

Conditions: Anxiety Disorder
Ductal Breast Carcinoma in Situ
Psychosocial Effects of Cancer and Its Treatment
Stage IA Breast Cancer
Stage IB Breast Cancer
Stage IIIC Breast Cancer
Depression
Lobular Breast Carcinoma in Situ
Stage IIIB Breast Cancer
Stage II Breast Cancer

Interventions: Other: counseling intervention
Other: educational intervention
Other: psychosocial support for caregiver

First Posted Date: 2012-11-08

Last Posted Date: 2018-02-08

Lead Sponsor: University of Washington

Target Recruit Count: 108

Registration Number: NCT01723943

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

Not Applicable

Completed

Conditions: Male Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions: Drug: vorinostat
Drug: anastrozole
Drug: letrozole
Drug: exemestane
Procedure: positron emission tomography
Radiation: F-18 16 alpha-fluoroestradiol
Radiation: fludeoxyglucose F 18
Other: laboratory biomarker analysis

First Posted Date: 2012-11-02

Last Posted Date: 2020-01-07

Lead Sponsor: University of Washington

Target Recruit Count: 15

Registration Number: NCT01720602

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Pacific Northwest Udall Center (PANUC) Clinical Core

Recruiting

Conditions: Parkinson Disease
Cognitive Impairment

First Posted Date: 2012-11-02

Last Posted Date: 2024-05-14

Lead Sponsor: University of Washington

Target Recruit Count: 2000

Registration Number: NCT01720810

Locations: 🇺🇸
VA Puget Sound Health Care System, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy